Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Uveitis

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Uveitis in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Uveitis: Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laengle, UW1
Trendelenburg, AU1
Markstein, R1
Nogues, V1
Provencher-Bollinger, A1
Roman, D1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Uveitis

ArticleYear
GLC756 decreases TNF-alpha via an alpha2 and beta2 adrenoceptor related mechanism.
    Experimental eye research, 2006, Volume: 83, Issue:5

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Agonists; Adrenergic beta-2 Receptor Antago

2006